Recombinant VEGF (Bevacizumab Biosimilar) antibody
The Mammalian Cells Monoclonal anti-VEGF (Bevacizumab Biosimilar) antibody is suitable to detect VEGF (Bevacizumab Biosimilar) in samples from Human.
Catalog No. ABIN7487772
$336.06
Plus shipping costs $50.00
Shipping to:
United States
Delivery in 7 to 10 Business Days
Quick Overview for Recombinant VEGF (Bevacizumab Biosimilar) antibody (ABIN7487772)
Target
VEGF (Bevacizumab Biosimilar)
Antibody Type
Recombinant Antibody
Reactivity
Human
Host
Mammalian Cells
Clonality
Monoclonal
Conjugate
This VEGF (Bevacizumab Biosimilar) antibody is un-conjugated
Application
Please inquire
Grade
Research Grade
-
-
Expression System
- Mammalian cells
-
Purpose
- Bevacizumab Biosimilar - Anti-VEGF mAb
-
Characteristics
- Antibody Type: IgG1
-
Purification
- Recombinant antibody expressed in mammalien cells and purified.
-
Isotype
- IgG1, IgG1 kappa
-
-
anti-VEGF (Bevacizumab Biosimilar) antibody
Research Grade Reactivity: Human ELISA Host: Humanized Monoclonal unconjugated Recombinant Antibody
-
-
Restrictions
- For Research Use only
-
-
-
Buffer
- PBS buffer pH 7.5
-
Storage
- 4 °C,-20 °C
-
Storage Comment
- 4°C for short term, -20°C for long term
-
-
- VEGF (Bevacizumab Biosimilar)
-
Target Type
- Biosimilar
-
Background
- Bevacizumab
Target
-
You are here:
